{{Drugbox|
|IUPAC_name = (1S,2R,18R,19R,22S,25R,28R,40S)- 48- {[(2S,3R,4S,5S,6R)- 3- {4- amino- 5- hydroxy- 4,6- dimethyloxan- 2- yloxy}- 4,5- dihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxy}- 22- (carbamoylmethyl)- 5,15- dichloro- 2,18,32,35,37- pentahydroxy- 19- 4- methyl- 2- (methylamino)pentanamido- 20,23,26,42,44- pentaoxo- 7,13- dioxa- 21,24,27,41,43- pentaazaoctacyclo1pentaconta- 3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49- pentadecaene- 40- carboxylic acid
| width=300
| image=Vancomycin.png
| CAS_number=1404-90-6
| ChemSpiderID = 14253
| ATC_prefix=A07
| ATC_suffix=AA09
| ATC_supplemental=ATC: XA01
| PubChem=14969
| DrugBank=APRD01287
| C=66 | H=75 | Cl=2 | N=9 | O=24
| molecular_weight = 1449.3 g.mol-1
| bioavailability= Negligible (oral)
| metabolism = Excreted unchanged
| elimination_half-life=4–11 hours (adults)
6-10 days (adults, impaired renal function)
| excretion = Renal
| pregnancy_category = B2 (Au), B (U.S.)
| legal_status = S4 (Au), POM (UK), ℞-only (U.S.)
| routes_of_administration= IV, oral
}}

Your changes have been saved.